Literature DB >> 15449065

Development of clinical celiac disease after pancreatoduodenectomy: a potential complication of major upper abdominal surgery.

Aljamir D Chedid1, Cleber R P Kruel, Marcio F Chedid, Ronaldo J S Torresini, Geraldo R Geyer.   

Abstract

BACKGROUND: Celiac disease is a gluten-induced disease of global malabsorption. There is a subset of patients with celiac disease who are free of major symptoms but who have typical damage to the intestinal mucosa (silent disease). We present the case of a 50-year-old white woman with no clinical symptoms of celiac disease who developed diarrhea and weight loss 12 weeks after a pancreatoduodenectomy for ampullary cancer.
METHODS: Microbiological and biochemical examination of the feces did not provide clues useful to diagnosis, and diarrhea was not affected by pancreatic enzyme replacement or administration of antiperistaltic drugs.
RESULTS: Review of the pathologic specimen and blood tests were compatible with celiac disease.
CONCLUSION: This clinical scenario illustrates that subclinical celiac disease may be an underdiagnosed cause of malabsorption after major upper gastrointestinal surgery and should be considered in the differential diagnosis of diarrhea after pancreatoduodenectomy.

Entities:  

Mesh:

Year:  2004        PMID: 15449065     DOI: 10.1007/s00423-004-0516-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  13 in total

1.  Coeliac disease diagnosed after pancreaticoduodenectomy.

Authors:  N Gebrayel; K Conlon; M Shike
Journal:  Eur J Surg       Date:  2000-09

2.  Celiac disease--how to handle a clinical chameleon.

Authors:  Alessio Fasano
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

3.  Duodeno-jejunal adenocarcinoma and coeliac disease.

Authors:  C H Mason; A A Dunk
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

4.  Coeliac disease in the year 2000: exploring the iceberg.

Authors:  C Catassi; I M Rätsch; E Fabiani; M Rossini; F Bordicchia; F Candela; G V Coppa; P L Giorgi
Journal:  Lancet       Date:  1994-01-22       Impact factor: 79.321

5.  Untractable diarrhea due to late onset celiac disease of the adult following pancreatoduodenectomy.

Authors:  U Boggi; R Bellini; E Rossetti; A Pietrabissa; F Mosca
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

6.  Coeliac disease clinically manifest after vagotomy and oesophagectomy.

Authors:  D ten Bokkel Huinink; P H de Meijer; A E Meinders
Journal:  Neth J Med       Date:  1996-12       Impact factor: 1.422

7.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

8.  Gastrointestinal malignancies in patients with celiac sprue.

Authors:  V E Pricolo; A A Mangi; B Aswad; K I Bland
Journal:  Am J Surg       Date:  1998-10       Impact factor: 2.565

9.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

Authors:  M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Celiac sprue after surgery of the upper gastrointestinal tract. Report of 10 patients with special attention to diagnosis, clinical behavior, and follow-up.

Authors:  J Bai; C Moran; C Martinez; S Niveloni; E Crosetti; A Sambuelli; L Boerr
Journal:  J Clin Gastroenterol       Date:  1991-10       Impact factor: 3.062

View more
  2 in total

1.  Silent celiac disease activated by pancreaticoduodenectomy.

Authors:  John T Maple; Randall K Pearson; Joseph A Murray; Darlene G Kelly; Luis F Lara; Andy C Fan
Journal:  Dig Dis Sci       Date:  2007-03-21       Impact factor: 3.199

Review 2.  Pancreatic endocrine and exocrine changes in celiac disease.

Authors:  Hugh J Freeman
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.